Cargando…
Enhanced anti-breast cancer efficacy of co-delivery liposomes of docetaxel and curcumin
The successful treatment of breast cancer is hampered by toxicity to normal cells, impaired drug accumulation at the tumor site, and multidrug resistance. We designed a novel multifunctional liposome, CUR-DTX-L, to co-deliver curcumin (CUR) and the chemotherapeutic drug docetaxel (DTX) for the treat...
Autores principales: | Ye, Xi, Chen, Xin, He, Ruixi, Meng, Wangyang, Chen, Weidong, Wang, Fengling, Meng, Xiangyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618653/ https://www.ncbi.nlm.nih.gov/pubmed/36324685 http://dx.doi.org/10.3389/fphar.2022.969611 |
Ejemplares similares
-
Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy
por: Li, Junxiu, et al.
Publicado: (2016) -
Curcumin enhances anti-cancer efficacy of either gemcitabine or docetaxel on pancreatic cancer cells
por: Liu, Pan, et al.
Publicado: (2020) -
Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment
por: Hu, Yuzhu, et al.
Publicado: (2020) -
New Drugs for Hepatic Fibrosis
por: Shan, Liang, et al.
Publicado: (2022) -
Caffeine in liver diseases: Pharmacology and toxicology
por: Shan, Liang, et al.
Publicado: (2022)